BCG VACCINE SSI

This brand name is authorized in Estonia, Hong Kong SAR China, Ireland, Lithuania, South Africa, Tunisia.

Active ingredients

The drug BCG VACCINE SSI contains one active pharmaceutical ingredient (API):

1
UNII D3GOY6203T - MYCOBACTERIUM BOVIS BCG
 

BCG vaccine is an immunostimulating agent. It has anti-tumor activity, but the exact mechanism of action is not known.
 
Read more about BCG vaccine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J07AN01 Tuberculosis, live attenuated J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AN Tuberculosis vaccines
Discover more medicines within J07AN01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1849989, 1852949
HK Department of Health Drug Office 44952, 46273
LT Valstybinė vaistų kontrolės tarnyba 1013929, 1060926, 1089206
TN Direction de la Pharmacie et du Médicament 3223011
ZA Health Products Regulatory Authority 29/30.1/0643

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈